Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Granules India receives establishment inspection report from USFDA

Granules India has received EIR from US Food and Drug Administration (USFDA), for Chantilly unit.

USFDA has issued establishment inspection report (EIR) for Granules Pharmaceuticals, Inc facility, a wholly owned foreign subsidiary of the company which is situated at Chantilly, Virginia, USA.

Moreover, this facility was inspected by USFDA in December 2017 and there was 1 observation during the inspection. The company had responded to the observation within the stipulated time frame.

Read EquityPandit’s Technical Analysis of Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile